SEC
SlamSEC
Search
Browse
Earnings
Aspira Women's Health Inc. — SlamSEC
Aspira Women's Health Inc.
OTC:
AWHL
In Vitro & In Vivo Diagnostic Substances
·
AUSTIN, TX
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$9.2M
FY 2024
Adj. EBITDA
-$18.6M
-203.1% margin
FY 2024
Net Income
-$16.7M
-182.3% margin
FY 2024
EPS (Diluted)
-$1.81
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$2.6M
FY 2024
Total Debt
$2.1M
FY 2024
Net Cash
$497,000
FY 2024
Enterprise Value
—
Debt / EBITDA
0.0x
FY 2024
EV / EBITDA
—
Employees
—